King Pharmaceuticals Reports Year-End and Fourth-Quarter 2007 ... - PharmaLive.com (press release)
Net sales of SKELAXIN(R) (metaxalone) totaled $114 million during the fourth quarter and $440 million for the year ended December 31, 2007, compared to $113 ...